Why Acadia Pharmaceuticals (ACAD) Will Get More Than $44 From Pfizer (PFE)

Why ACAD stock will be the next Medivation. Pfizer, Gilead, Teva, Bristol-Myers, Otsuka & AbbVie are all companies that would want Nuplazid & Acadia Pharma

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , , , , , | 1 Comment

BNL’s Top Calls: RAD, AMZN, BMY, FNMA stock & BAC stock

BNL Finance’s top calls involve RAD, AMZN, BMY, FNMA stock, BAC stock, XPO, FB, and UAA among others. However, stock performance is not the only factor.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , , , , , , , , , , , , | 3 Comments

What JUNO Stock & KITE Stock Owners Can Learn From Bristol-Myers Squibb Co (NYSE:BMY)

Bristol-Myers Squibb Co (NYSE:BMY) and Merck & Co., Inc. (NYSE:MRK) prove that trial design and strategy matters. This is something Kite Pharma Inc (NASDAQ:KITE) and Juno Therapeutics Inc (NASDAQ:JUNO) investors must notice.

Posted in Healthcare & Biotech, Hot Stocks | Tagged , , , , , , , | Leave a comment

Gilead Stock Price to Soar Behind Acquisition (NASDAQ:GILD)

Gilead stock price multiple coupled with GILD’s corporate outlook make it a great acquisition target for Pfizer, Merck, or even Johnson & Johnson.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , | 2 Comments

Acadia Pharmaceuticals (NASDAQ:ACAD) Plan for Nuplazid & Outlook for ACAD Stock Becomes Clear

Acadia Pharmaceuticals just told investors that a major marketing partnership for Nuplazid or acquisition is not going to happen, and ACAD stock owners will be better off because of it.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , | Leave a comment